Gyre Therapeutics, Inc. (GYRE)
NASDAQ·Healthcare·Biotechnology
$6.03
+3.52%
Mkt Cap $575.38M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$17.00
Range $16.00 – $18.00
Implied Upside
+182.2%
Consensus $17.00 vs current $6.03
NASDAQ·Healthcare·Biotechnology
$6.03
+3.52%
Mkt Cap $575.38M
No recent rating data.
Price Target (2 analysts)
$17.00
Range $16.00 – $18.00
+182.2%
Consensus $17.00 vs current $6.03